Sandeep Laumas
CIK 1721664 · CFO and CBO · last filed 2026-07-28
Sandeep Laumas is a CFO and CBO who has filed 37 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for UNCY, was dated Jul 28, 2026. Across all open-market trades the lifetime net is −$662.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $91.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$91.7K
5
37
-$662.7K
Filer Profile
2800 EXECUTIVE WAY
RALEIGH, MA 27615
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNCY | Director | — | $5.31 | — | $0 | 5 | 2026-07-28 |
| BTAI | Director | — | $0.07 | — | $0 | 8 | 2026-01-12 |
| TIL | CFO and CBO | 12,461 | $7.36 | $91.7K | -$701.7K | 9 | 2025-09-12 |
| 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Director | 40,939 | $0.07 | $3.0K | $0 | 4 | 2020-07-08 |
| 9 METERS BIOPHARMA, INC. (INNT) Delisted | CEO, Executive Chairman | 776,373 | — | — | $38.9K | 10 | 2019-08-27 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-28 | UNCY | Grant (A) | — | $0 | EDGAR |
| 2026-06-15 | UNCY | Grant (A) | — | $0 | EDGAR |
| 2026-05-18 | UNCY | Grant (A) | — | $0 | EDGAR |
| 2026-01-12 | BTAI | Grant (A) | — | $0 | EDGAR |
| 2025-09-12 | TIL | Mixed | — | -$339.6K | EDGAR |
| 2025-09-10 | TIL | Notice (144) | −30,000 | -$701.6K | EDGAR |
| 2025-07-30 | UNCY | Grant (A) | — | $0 | EDGAR |
| 2025-04-28 | TIL | Grant (A) | — | $0 | EDGAR |
| 2024-09-23 | TIL | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | BTAI | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.